Impact BioMedical, Inc. (IBO) is a publicly traded Healthcare sector company. As of August 7, 2026, IBO trades at $0.44 with a market cap of $48.61M and a P/E ratio of -1.16. IBO moved -3.48% today. Year to date, IBO is -13.06%; over the trailing twelve months it is -26.34%. Its 52-week range spans $0.36 to $6.17. Rallies surfaces IBO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Impact BioMedical, Inc. (IBO) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. IBO moved -3.48% today.
| Metric | Value |
|---|---|
| Price | $0.44 |
| Market Cap | $48.61M |
| P/E Ratio | -1.16 |
| EPS | $-0.38 |
| Dividend Yield | 0.00% |
| 52-Week High | $6.17 |
| 52-Week Low | $0.36 |
| Volume | 9.01K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-11.87M |
| Gross Margin | 0.00% |
IBO analyst coverage data. Average price target: $0.00.